Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer

Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer

An amendment to this paper has been published and can be accessed via the original article.

Bibliographic Details
Main Authors: Liying Ma, Xing Bian, Wenchu Lin
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:https://doi.org/10.1186/s13046-020-01805-6
id doaj-5d8b883f3d1e47439168f06e7d7624f1
record_format Article
spelling doaj-5d8b883f3d1e47439168f06e7d7624f12021-01-10T12:08:27ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662021-01-014011110.1186/s13046-020-01805-6Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancerLiying Ma0Xing Bian1Wenchu Lin2High Magnetic Field Laboratory, Chinese Academy of SciencesHigh Magnetic Field Laboratory, Chinese Academy of SciencesHigh Magnetic Field Laboratory, Chinese Academy of SciencesAn amendment to this paper has been published and can be accessed via the original article.https://doi.org/10.1186/s13046-020-01805-6
collection DOAJ
language English
format Article
sources DOAJ
author Liying Ma
Xing Bian
Wenchu Lin
spellingShingle Liying Ma
Xing Bian
Wenchu Lin
Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
Journal of Experimental & Clinical Cancer Research
author_facet Liying Ma
Xing Bian
Wenchu Lin
author_sort Liying Ma
title Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
title_short Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
title_full Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
title_fullStr Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
title_full_unstemmed Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
title_sort correction to: the dual hdac-pi3k inhibitor cudc-907 displays single-agent activity and synergizes with parp inhibitor olaparib in small cell lung cancer
publisher BMC
series Journal of Experimental & Clinical Cancer Research
issn 1756-9966
publishDate 2021-01-01
description An amendment to this paper has been published and can be accessed via the original article.
url https://doi.org/10.1186/s13046-020-01805-6
work_keys_str_mv AT liyingma correctiontothedualhdacpi3kinhibitorcudc907displayssingleagentactivityandsynergizeswithparpinhibitorolaparibinsmallcelllungcancer
AT xingbian correctiontothedualhdacpi3kinhibitorcudc907displayssingleagentactivityandsynergizeswithparpinhibitorolaparibinsmallcelllungcancer
AT wenchulin correctiontothedualhdacpi3kinhibitorcudc907displayssingleagentactivityandsynergizeswithparpinhibitorolaparibinsmallcelllungcancer
_version_ 1724343347026329600

Similar Items